DNDI-6148 是一种治疗内脏利什曼病的新的临床前候选药物。
生物活性 | DNDI-6148 is a novel preclinical candidate for the treatment of visceral leishmaniasis. |
IC50& Target | |
分子量 | |
Formula | |
CAS 号 | |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |